Oral Submucous Fibrosis and Its Relation with Stromal Vascularity: A Systematic Review

##plugins.themes.bootstrap3.article.main##

  •   Sayed Nishat Abdul

Abstract

Oral submucous fibrosis (OSMF) is a chronic progressive, scarring disease affecting oral, oropharyngeal, and sometimes the esophageal mucosa. It is characterized by the progressive fibrosis of the submucosal tissue. The pathogenesis of OSMF has been directly related to the habit of chewing areca nut and its commercial preparation, which is widespread in Indian subcontinent and Southeast Asia. Malignant transformation has been reported in 7%–12% cases of OSMF. Histopathological spectrum of OSMF includes the apparent alterations observed in the epithelium and connective tissue. Vascularity in OSMF has always been a matter of debate. The prevailing concept is that epithelial atrophy occurs due to lack of perfusion. The present systemic review was done to evaluate oral submucous fibrosis and its relation with stromal vascularity.


Keywords: Oral submucous fibrosis, vascularity, epithelial atrophy

References

Desai SR, Mamatha GS, Khatri MJ, Shetty JS. Immunochemical expression of CD34 for characterization and quantification of mucosal vasculature and its probable role in malignant transformation of atrophic epithelium in oral submucous fibrosis. Oral Oncol. 2010; 46: 553–58.

Rajendran R. Oral submucous fibrosis: Etiology, pathogenesis, and future research. Bull World Health Organ. 1994;72: 985–96.

Shieh TY, Yang JF. Collagenase activity in oral submucous fibrosis. Proc Natl Sci Counc Repub China B 1992; 16:106-10.

Yang SF, Hsieh YS, Tsai CH, Chen YJ, Chang YC. Increased plasminogen activator inhibitor-1/tissue type plasminogen activator ratio in oral submucous fibrosis. Oral Dis 2007; 13:234-8.

Rajendran R, Paul S, Mathews PP, Raghul J, Mohanty M. Characterization and quantification of mucosal vasculature in oral submucus fibrosis. Indian J Dent Res. 2005; 16:83–89.

Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakuasuriya S. Oral submucous fibrosis: Review on etiology and pathogenesis. Oral Oncol 2006; 42:561-8.

Lalli A, Tilakaratne WM, Ariyawardana A, Fitchett C, Leigh IM, Hagi-Pavli E, et al. An altered keratinocyte phenotype in oral submucous fibrosis: Correlation of keratin K17 expression with disease severity. J Oral Pathol Med 2008; 37:211-20.

Takeda K, Hatamochi A, Ueki H. Increased number of mast cells accompany enhanced collagen synthesis in linear localized scleroderma. Arch Dermatol Res. 1989; 281:288–90.

Sabarinath B, Sriram G, Saraswathi TR, Sivapathasundharam B. Immunohistochemical evaluation of mast cells and vascular endothelial proliferation in oral submucous fibrosis. Indian J Dent Res. 2011; 22:116–21.

Hannen EJ, Riediger D. The quantification of angiogenesis in relation to metastasis in oral cancer: A review. Int J Oral Maxillofacial Surg. 2004; 33:02–07.

Rajalalitha P, Vali S. Molecular pathogenesis of oral submucous fibrosis: A collagen metabolic disorder. J Oral Pathol Med 2005; 34:321-8.

Auluck A, Rosin MP, Zhang L, Sumanth KN. Oral submucous fibrosis, a clinically benign but potentially malignant disease: Report of 3 cases and review of the literature. J Can Dent Assoc 2008; 74:735-40.

Hazarey VK, Erlewad DM, Mundhe KA, Ughade SN. Oral submucous fibrosis: Study of 1000 cases from central India. J Oral Pathol Med 2007; 36:12-7.

Fang CY, Han WN, Fong DY. A morphometric study on the microvessel in oral submucous fibrosis. Hunan Yi Ke Da Xue Xue Bao. 2000; 25:55–7.

Singh M, Chaudhary AK, Pandya S, Debnath S, Singh M, Singh PA, et al. Morphometric analysis in potentially malignant head and neck lesions: Oral submucous fibrosis. Asian Pac J Cancer Prev. 2010; 11:257–60.

Debnath S, Mitra B, Paul B, Saha TN, Maity A. Morphometric analysis of oral submucous fibrosis and its correlation with histological staging and clinical severity of trismus. Egypt J Ear Nose Throat Allied Sci. 2013; 14:85–90.

Rajendran R, Paul S, Mathews PP, Raghul J, Mohanty M. Characterization and quantification of mucosal vasculature in oral submucus fibrosis. Indian J Dent Res. 2005; 16: 83–89.

Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S. Oral submucous fibrosis: Review on aetiology and pathogenesis. Oral Oncol. 2006; 42: 561–8.

Murgod VV, Kale AD, Angadi PV, Hallikerimath S. Morphometric analysis of the mucosal vasculature in oral submucous fibrosis and its comparison with oral squamous cell carcinoma. Journal of oral science.2014; 56:173-78.

Tekade SA, Chaudhary MS, Tekade SS, Sarode SC, Wanjari SP, Gadbail AR et al. Early stage oral submucous fibrosis is characterized by increased vascularity as opposed to advanced stages. Journal of clinical and diagnostic research. 2017; 11:92-96.

Hande AH, Chaudhary MS, Gawande MN, Gadabali AR, Zade PR, Bajaj S, et al, Oral submucous fibrosis: An enigmatic morpho-insight. J Can Res Ther.2019;15: 463-9.

Downloads

Download data is not yet available.

##plugins.themes.bootstrap3.article.details##

How to Cite
Abdul, S. (2020). Oral Submucous Fibrosis and Its Relation with Stromal Vascularity: A Systematic Review. European Journal of Medical and Health Sciences, 2(2). https://doi.org/10.24018/ejmed.2020.2.2.162